EMEA-001198-PIP02-16
Key facts
| Invented name |
Akynzeo
|
| Active substance |
|
| Therapeutic area |
Other
|
| Decision number |
P/0358/2016
|
| PIP number |
EMEA-001198-PIP02-16
|
| Pharmaceutical form(s) |
Powder for solution for infusion
|
| Condition(s) / indication(s) |
Prevention of chemotherapy-induced nausea and vomiting
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Helsinn Birex Pharmaceuticals Limited
|
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|